MicrobiologybioRxiv
Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern
A. Marzi, A. Griffin, K. L. O'Donnell…·R. F. Relich
The paper examines serum from early pandemic SARS-CoV-2 patients, finding limited cross-neutralization against variants of concern.
DOI 10.1038/s41598-022-07960-4